John O. Mascarenhas, MD, and Kapila Viges discuss how MPN care is being transformed by aligning research with patient-centered outcomes. Physician’s Weekly (PW) met with John O. Mascarenhas, MD, and Kapila Viges to learn how the latest research...
Oncology / Hematology
RELEVANT ARTICLES IN Oncology / Hematology
Year in Review – NSCLC
Year in Review – NSCLC
A curated review of what has happened in non-small cell lung cancer (NSCLC) research in 2024, including FDA approvals, updated guidelines, and more...
Year in Review – Metastatic Breast Cancer
Year in Review – Metastatic Breast Cancer
A curated review of what has happened in metastatic breast cancer research in 2024, including FDA approvals, trials, updated guidelines, and more...
Year in Review – Early Breast Cancer
Year in Review – Early Breast Cancer
A curated review of what has happened in early breast cancer research in 2024, including FDA approvals, trials, updated guidelines, and more...
Tackling Racial Gaps in Fatalism to Improve Indolent Blood Cancer Outcomes
Tackling Racial Gaps in Fatalism to Improve Indolent Blood Cancer Outcomes
Cancer-related fear and fatalism are more prevalent in patients of racial minority groups with indolent blood cancer, potentially impacting outcomes.
Advances in Managing Cutaneous Malignancies Beyond Melanoma
Advances in Managing Cutaneous Malignancies Beyond Melanoma
The following is a summary of “An Updated Review of Immune Checkpoint Inhibitors in Cutaneous Oncology: Beyond Melanoma,” published in the January 2025 issue of Oncology by Pham et al. Over the past decade, immune checkpoint inhibitors (ICIs) have emerged as a...
Advertisement
Surrogate Endpoints in Expedited Approval Challenges and Trends
Surrogate Endpoints in Expedited Approval Challenges and Trends
The following is a summary of “Expedited pathway insights: Unveiling oncology and non-oncology drug approvals and withdrawals of USFDA and EMA,” published in the January 2025 issue of Oncology by Chaugule et al. Health authorities undertake rigorous evaluations of...
Genomic Classifier Tests Play Heterogeneous Role in Prostate Cancer Risk Classification
Genomic Classifier Tests Play Heterogeneous Role in Prostate Cancer Risk Classification
TUESDAY, Jan. 21, 2025 (HealthDay News) -- For patients with localized prostate cancer (PCa), tissue-based genomic classifiers (GCs) do not consistently influence risk classification or treatment decisions, according to a review published online Jan. 21 in the...
Advancing RCC Treatment: Biomarkers, Combination Therapies, & Emerging Innovations – 2024 Roundup
Advancing RCC Treatment: Biomarkers, Combination Therapies, & Emerging Innovations – 2024 Roundup
Highlights from three RCC treatment strategy panel discussions focused on biomarkers, combo therapies, toxicity management, and emerging therapeutic targets.
Tackling Racial Gaps in Fatalism to Improve Indolent Blood Cancer Outcomes
Tackling Racial Gaps in Fatalism to Improve Indolent Blood Cancer Outcomes
Cancer-related fear and fatalism are more prevalent in patients of racial minority groups with indolent blood cancer, potentially impacting outcomes.
Advances in Managing Cutaneous Malignancies Beyond Melanoma
Advances in Managing Cutaneous Malignancies Beyond Melanoma
The following is a summary of “An Updated Review of Immune Checkpoint Inhibitors in Cutaneous Oncology: Beyond Melanoma,” published in the January 2025 issue of Oncology by Pham et al. Over the past decade, immune checkpoint inhibitors (ICIs) have emerged as a...
Surrogate Endpoints in Expedited Approval Challenges and Trends
Surrogate Endpoints in Expedited Approval Challenges and Trends
The following is a summary of “Expedited pathway insights: Unveiling oncology and non-oncology drug approvals and withdrawals of USFDA and EMA,” published in the January 2025 issue of Oncology by Chaugule et al. Health authorities undertake rigorous evaluations of...
Genomic Classifier Tests Play Heterogeneous Role in Prostate Cancer Risk Classification
Genomic Classifier Tests Play Heterogeneous Role in Prostate Cancer Risk Classification
TUESDAY, Jan. 21, 2025 (HealthDay News) -- For patients with localized prostate cancer (PCa), tissue-based genomic classifiers (GCs) do not consistently influence risk classification or treatment decisions, according to a review published online Jan. 21 in the...
Advancing RCC Treatment: Biomarkers, Combination Therapies, & Emerging Innovations – 2024 Roundup
Advancing RCC Treatment: Biomarkers, Combination Therapies, & Emerging Innovations – 2024 Roundup
Highlights from three RCC treatment strategy panel discussions focused on biomarkers, combo therapies, toxicity management, and emerging therapeutic targets.
CONDITION SPOTLIGHTS
Advertisement
SABCS 2024
Physician’s Weekly-created content featuring key opinion leaders sharing their perspectives on eBC & mBC from different vantage points at SABCS 2024.
Q&A: Identifying an Employment Breach of Contract
Q&A: Identifying an Employment Breach of Contract
Dr. MedLaw addresses physicians' questions regarding medical law, providing guidance in this article to a clinician experiencing employment breach of contract.
Q&A: How to Handle Employment Breach of Contract
Q&A: How to Handle Employment Breach of Contract
Dr. MedLaw addresses physicians' questions regarding medical law, providing guidance in this article to a clinician experiencing employment breach of contract.
Wings of Empowerment: Applying Aviation Wisdom to Patient Journeys
Wings of Empowerment: Applying Aviation Wisdom to Patient Journeys
Lessons drawn from aviation can empower patients, inspiring patient journeys by encouraging them to rise above limits with a bird's-eye view.
CME / CE
In Multifocal HCC, Survival Better With Liver Resection Vs Tumor Ablation
This course discusses the overall survival with liver resection versus tumor ablation in patients with multifocal hepatocellular carcinoma
PODCAST
Advertisement
MORE STORIES IN Oncology / Hematology
FILTER ARTICLES BY:
Advertisement
PODCAST
CARTOONS
BUSINESS OF MEDICINE
Transfusion Medicine in 2025: Challenges, Innovations, & the Clinicians’ Role in Driving Blood Donation
Transfusion Medicine in 2025: Challenges, Innovations, & the Clinicians’ Role in Driving Blood Donation
ADRP Advisory Board Member Amanda Hess discusses advances in transfusion medicine, challenges blood centers face, and how clinicians can boost blood donation.
Healthcare’s Financial Fault Line: How to Navigate Patient Debt for Improved Health Outcomes
Healthcare’s Financial Fault Line: How to Navigate Patient Debt for Improved Health Outcomes
Rising patient debt strains the US healthcare system, but improving financial assistance, revenue management, and patient engagement can help reduce the burden.
How Flexible Workweeks Could Reduce Physician Burnout & Improve Patient Care
How Flexible Workweeks Could Reduce Physician Burnout & Improve Patient Care
A 4-day workweek may reduce physician burnout, lower costs, improve patient care, and boost work-life balance, benefiting healthcare systems overall.
ADVERTISEMENT
Stay connected to the latest news with Physician’s Weekly
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.